ULTRAWAVE II EX 1320— 510(k) K070805

Clearance details

Applicant

Quanta System Spa

Product code

Code GEX

Device class

Class 2

Regulation

21 CFR 878.4810

Advisory panel

General, Plastic Surgery

Date received

2007-03-23

Decision date

2007-07-11

Decision

Substantially Equivalent

Clearance type

Traditional

Location

Washington, DC, US

• K241973 — SmartIPL_NI System2026-09-19
• K252723 — Dynamis Pro Family2026-09-19
• K261047 — Dental Diode Laser Device (Laser-Pen)2026-09-18
• K261673 — LED Therapy Device (QLXY-01)2026-09-17
• K261817 — Diode Laser Therapy System (PZ-BDT67-01, PZ-BDT67-02)2026-09-17

• K240983 — Discovery Pico; Discovery Pico Plus; Discovery Pico Derm2025-06-06
• K243588 — Single Use CO2 Laser Fiber (HAF005001)2025-02-19
• K241092 — Youlaser PRIME; Youlaser PRIME CO2; Youlaser PRIME MT2024-10-10
• K242251 — Litho 60; Litho 100; Litho 1502024-09-03
• K232236 — Echo2023-10-20

Death

33

Injury

3,045

Malfunction

12,903

Other

25

Total

16,006

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

• Z-0693-2013 — Ultrawave II EX 1320/ Ultrawave III EX 1320 Powered Laser Surgical Instrument. Nd:YAG 1064 nm: Coagulation and hemostasis of benign vascular lesions (e.g. port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg and spider veins, scars, straie and psoriasis; Treatment of benign pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments; Treatment of facial wrinkles (e.g. periocular and periorbital); Removal of unwanted hair, for the stable longterm, or permanent, hair reduction, including Fitzpatrick IVI and suntanned skin types; For the treatment of pseudofolliculitis barbae (PFB); Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar; For use on all skin types (Fitzpatrick IVI) including tanned skin. Alexandrite 755 nm: Coagulation and hemostasis of vascular lesions and the removal and permanent reduction of unwanted hair in Fitzpatrick skin types 1VI, including suntanned skin types; Pigmented lesions; Wrinkles. Nd: YAG 1320 nm: General surgery and dermatology for the incision, excision, ablation, vaporization, coagulation and hemostasis of soft tissue; Treatment of periorbital and periocular wrinkles, fine lines and wrinkles, treatment of back acne and atrophic acne scars. IPL: Permanent hair reduction; Photocoagulation of dermatological vascular lesion (i.e. face telangiectasia); Photothermolysis of blood vessels (treatment of facial and leg veins); Treatment of benign pigmented lesions.Class II·Terminated·Quanta System, S.p.A.·20121107

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K070805.